NVO - Eli Lilly wins U.K. backing for diabetes drug Mounjaro
2023-09-08 07:14:27 ET
More on Eli Lilly
- Seeking Alpha’s Quant Rating on Eli Lilly
- Historical earnings data for Eli Lilly
- Dividend scorecard for Eli Lilly
- Financial information for Eli Lilly
- Eli Lilly And Novo Nordisk: Are Weight Loss Drugs A Global Revolution Or Short-Lived Fad?
- Sell Eli Lilly And Buy This Coiled-Spring Dividend Aristocrat Instead
- Eli Lilly Q2: Dividends Don't Lie
- Eli Lilly: Q2 And 2023 Revised Guidance Impressive, But Key Is Wegovy Data
- Researchers study weight loss drugs in dementia and addiction
- Lilly, Novo Nordisk top pharma performers in August; AstraZeneca, Roche lag
- Senators ask Novo Nordisk, Lilly, Sanofi for details on discount insulin programs
- Medicare lists first ten drugs selected for pricing negotiations
For further details see:
Eli Lilly wins U.K. backing for diabetes drug Mounjaro